company background image
ME1 logo

Melodiol Global Health ASX:ME1 Stock Report

Last Price

AU$0.005

Market Cap

AU$1.6m

7D

25.0%

1Y

-97.5%

Updated

28 Mar, 2024

Data

Company Financials

Melodiol Global Health Limited

ASX:ME1 Stock Report

Market Cap: AU$1.6m

ME1 Stock Overview

Melodiol Global Health Limited develops, registers, and commercializes pharmaceutical-grade cannabis, and hemp-based nutraceutical products and treatments for human and other health in Europe, Canada, the Asia Pacific, the United States, and internationally.

ME1 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health2/6
Dividends0/6

Melodiol Global Health Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Melodiol Global Health
Historical stock prices
Current Share PriceAU$0.005
52 Week HighAU$0.44
52 Week LowAU$0.004
Beta2.62
1 Month Change-28.57%
3 Month Change-87.50%
1 Year Change-97.50%
3 Year Change-99.88%
5 Year Change-99.95%
Change since IPO-99.90%

Recent News & Updates

Investors Give Melodiol Global Health Limited (ASX:ME1) Shares A 59% Hiding

Mar 02
Investors Give Melodiol Global Health Limited (ASX:ME1) Shares A 59% Hiding

Recent updates

Investors Give Melodiol Global Health Limited (ASX:ME1) Shares A 59% Hiding

Mar 02
Investors Give Melodiol Global Health Limited (ASX:ME1) Shares A 59% Hiding

Here's Why Creso Pharma (ASX:CPH) Can Afford Some Debt

May 11
Here's Why Creso Pharma (ASX:CPH) Can Afford Some Debt

Shareholder Returns

ME1AU PharmaceuticalsAU Market
7D25.0%1.1%1.5%
1Y-97.5%44.7%11.6%

Return vs Industry: ME1 underperformed the Australian Pharmaceuticals industry which returned 44.7% over the past year.

Return vs Market: ME1 underperformed the Australian Market which returned 11.6% over the past year.

Price Volatility

Is ME1's price volatile compared to industry and market?
ME1 volatility
ME1 Average Weekly Movement78.0%
Pharmaceuticals Industry Average Movement10.6%
Market Average Movement8.7%
10% most volatile stocks in AU Market17.1%
10% least volatile stocks in AU Market3.2%

Stable Share Price: ME1's share price has been volatile over the past 3 months.

Volatility Over Time: ME1's weekly volatility has increased from 50% to 78% over the past year.

About the Company

FoundedEmployeesCEOWebsite
2015n/aWill Layhttps://melodiolglobalhealth.com

Melodiol Global Health Limited develops, registers, and commercializes pharmaceutical-grade cannabis, and hemp-based nutraceutical products and treatments for human and other health in Europe, Canada, the Asia Pacific, the United States, and internationally. The company develops and commercializes therapeutic products; develops and sells beauty and personal care products under the Green Goo, Southern Butter, and Goodgoo brands; and cultivates, processes, and sells cannabis products. Its products include cannaQIX, a nutraceutical product containing hemp oil extract, and vitamins and minerals in a lozenge delivery system; the ImpACTIVE Pro Releaf Stick to provide relief to muscle aches, particularly in professional sport, and acts as an alternative to pharmacological solutions sold through online channels; Ritual Green, a dried flower; Ritual Sticks for pre-rolled joints; and Ritual Gold, a handheld vapouriser.

Melodiol Global Health Limited Fundamentals Summary

How do Melodiol Global Health's earnings and revenue compare to its market cap?
ME1 fundamental statistics
Market capAU$1.63m
Earnings (TTM)-AU$35.52m
Revenue (TTM)AU$19.04m

0.1x

P/S Ratio

-0.1x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
ME1 income statement (TTM)
RevenueAU$19.04m
Cost of RevenueAU$18.10m
Gross ProfitAU$937.00k
Other ExpensesAU$36.46m
Earnings-AU$35.52m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)-0.087
Gross Margin4.92%
Net Profit Margin-186.54%
Debt/Equity Ratio-232.0%

How did ME1 perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.